Status:
COMPLETED
IMaging Della PLAcca Carotidea
Lead Sponsor:
Enrico Ammirati
Conditions:
Carotid Artery Plaque
Atherosclerosis
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
Background-White matter hyperintensities (WMH), patchy areas of hyperintense signal on T2-weighted or Fluid Attenuated Inversion Recovery sequences on brain magnetic resonance imaging (MRI), are belie...
Detailed Description
* Ischemic stroke and vascular cognitive impairment pose a massive clinical, social and economic burden. Disruption of carotid plaques, often non-obstructive, with subsequent thrombosis and distal emb...
Eligibility Criteria
Inclusion
- \- bearing an asymptomatic carotid stenosis of 30-70% in diameter, as established by Doppler-measured peak systolic flow velocity, according to the Society of Radiologists in Ultrasound Consensus Conference (Grant et al. Radiology 2003).
Exclusion
- pregnancy or possibility of pregnancy,
- history of allergic diathesis,
- history of stroke or transitory ischemic attack,
- previous carotid artery stenting or carotid endarterectomy,
- history of autoimmune vasculitis,
- History of drug abuse, alcohol abuse or any psychiatric or social condition which may contraindicate the participation to a clinical study
- life expectancy of less than 18 months due to underlying medical conditions,
- presence of cognitive impairment preventing the patient from providing informed consent,
- Atrial fibrillation or previous cardiac surgery or positioning of intracardiac devices (excluded coronary stents) as potential confounding causes of cerebral ischemic damage,
- Known patent foramen ovale (PFO) necessitating anti-platelet treatment
- Current anti-coagulation,
- Previous infections to the central nervous system (CNS)
- Previous surgery to the CNS
- History of anoxic damage to the CNS
- Dementia
- Contraindications to computed tomography angiography (CTA, estimated Glomerular Filtration Rate\<60 mL/min; history of allergic reaction to iodinated contrast media),
- Specific contraindication to MRI:
- Claustrophobia
- Sickle cell anemia
- Systemic mastocytosis
- Implanted cardiac devices (i.e. pacemakers, implantable cardioverter defibrillators)
- Vascular clips
- Vertebral distractors
- Infusion pumps
- Neurostimulators
- Liquor derivations
- Any device which could be dispositioned in the presence of a strong magnetic field
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03333330
Start Date
April 1 2012
End Date
October 1 2017
Last Update
February 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.